Cargando…
Drug resistance in cancer
Cancer Research UK has recently sponsored a meeting, organized by the UK Medical Research Council, on cancer drug resistance. Several of the molecular mechanisms responsible for this clinical outcome, such as DNA interstrand crosslink repair, apoptosis evasion, cytochrome P450 and P-glycoprotein, we...
Autores principales: | Yagüe, E, Raguz, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361669/ https://www.ncbi.nlm.nih.gov/pubmed/16234820 http://dx.doi.org/10.1038/sj.bjc.6602821 |
Ejemplares similares
-
Resistance to chemotherapy: new treatments and novel insights into an old problem
por: Raguz, S, et al.
Publicado: (2008) -
Highlights of Children with Cancer UK’s Workshop on Drug Delivery in Paediatric Brain Tumours
por: Nailor, Audrey, et al.
Publicado: (2016) -
Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
por: Van Nuffel, An MT, et al.
Publicado: (2015) -
Drug-drug interactions in older patients with cancer: a report from the 15th Conference of the International Society of Geriatric Oncology, Prague, Czech Republic, November 2015
por: Stepney, Rob, et al.
Publicado: (2016) -
Malaria genomics meets drug-resistance phenotyping in the field
por: Hunt, Paul, et al.
Publicado: (2009)